论文部分内容阅读
目的研究和分析奥美拉挫三联疗法在治疗消化性溃疡中的临床效果。方法结果观察组的总有效率显著优于对照组,组间差异具有统计学意义(P<0.05);两组间治疗后比较中观察组呈阳性率明显少于对照组,差异有统计学意义(P<0.05);观察组患者在治疗7d、14d、21d和28d腹痛发生率均低于对照组,组间差异具有统计学意义(P<0.05);两组患者不良反应比较无明显差异,不具有统计学意义(P>0.05)。结论奥美拉唑三联疗法能有效抑制幽门螺杆菌,愈合溃疡面的效果,值得临床广泛推广。
Objective To study and analyze the clinical efficacy of Omeprazole triple therapy in the treatment of peptic ulcer. Methods Results The total effective rate of the observation group was significantly better than that of the control group, the difference was statistically significant (P <0.05); between the two groups after treatment, the positive rate of the observation group was significantly less than the control group, the difference was statistically significant (P <0.05). The incidence of abdominal pain in the observation group at 7d, 14d, 21d and 28d after treatment was lower than that in the control group (P <0.05). There was no significant difference between the two groups in adverse reactions, Not statistically significant (P> 0.05). Conclusion Omeprazole triple therapy can effectively inhibit the effect of Helicobacter pylori, ulcer healing, it is worth widely clinical promotion.